Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bowen

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopeniaHagop Kantarjian, Pierre Fenaux, Mikkael A Sekeres, et al.
Cancer Medicine|December 19, 2022
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT projectFabio Efficace, Karin Koinig, Francesco Cottone, et al.
Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.
Plos One|April 10, 2008
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblastsJacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour, et al.
The Lancet. Oncology|September 19, 2015
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Transfusion|February 7, 2024
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCERena Buckstein, Jeannie Callum, Anca Prica, et al.
Blood|August 4, 2005
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeAlexander Sternberg, Sally Killick, Tim Littlewood, et al.
British Journal of Haematology|January 22, 2020
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trialSimon J Stanworth, Sally Killick, Zoe K McQuilten, et al.
Plos One|September 8, 2022
Safety assessment of Mpp75Aa1.1, a new ETX_MTX2 protein from Brevibacillus laterosporus that controls western corn rootwormCunxi Wang, Gregory J Bean, Chun Ju Chen, et al.
British Journal of Haematology|December 27, 2021
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemiaThomas Coats, Daniel Bean, Aymeric Basset, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopeniaHagop Kantarjian, Pierre Fenaux, Mikkael A Sekeres, et al.
Cancer Medicine|December 19, 2022
Raising the standards of patient-centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS-RIGHT projectFabio Efficace, Karin Koinig, Francesco Cottone, et al.
Hemasphere|November 15, 2019
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults: Recommendations From the European Hematology Association and the European LeukemiaNetRaphael Itzykson, Pierre Fenaux, David Bowen, et al.
Plos One|April 10, 2008
The role of the iron transporter ABCB7 in refractory anemia with ring sideroblastsJacqueline Boultwood, Andrea Pellagatti, Maryam Nikpour, et al.
The Lancet. Oncology|September 19, 2015
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trialAlan K Burnett, Nigel H Russell, Robert K Hills, et al.
Transfusion|February 7, 2024
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC-ENHANCERena Buckstein, Jeannie Callum, Anca Prica, et al.
Blood|August 4, 2005
Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndromeAlexander Sternberg, Sally Killick, Tim Littlewood, et al.
British Journal of Haematology|January 22, 2020
Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trialSimon J Stanworth, Sally Killick, Zoe K McQuilten, et al.
Plos One|September 8, 2022
Safety assessment of Mpp75Aa1.1, a new ETX_MTX2 protein from Brevibacillus laterosporus that controls western corn rootwormCunxi Wang, Gregory J Bean, Chun Ju Chen, et al.
British Journal of Haematology|December 27, 2021
A novel algorithmic approach to generate consensus treatment guidelines in adult acute myeloid leukaemiaThomas Coats, Daniel Bean, Aymeric Basset, et al.
Pageof 10